Stay updated on Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial page.

Latest updates to the Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial page
- Check4 days agoChange DetectedThe page versioning shows a new revision, v3.5.0, added and the previous revision, v3.4.3, removed.SummaryDifference0.1%

- Check11 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the page.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.4.2 is now shown and the prior notice about government funding (v3.4.1) has been removed; these are administrative updates that do not alter the study details or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check46 days agoChange DetectedAdded a site-wide notice about government funding and operating status and updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check54 days agoChange DetectedGlossary toggle added; the QC status label now reads 'Last Update Submitted that Met QC Criteria' and the footer includes 'No FEAR Act Data' with revision updated to v3.4.0, replacing the previous 'Last Update Submitted that met QC Criteria' and revision v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange DetectedKey documents including the Statistical Analysis Plan and Study Protocol were removed from the Study Documents section, along with related items such as IPD plans.SummaryDifference17%

Stay in the know with updates to Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial page.